Sign In
Buy LH
$258.92
+1.22 (+0.473%)
At Close: Jun 03, 2026
National Kidney Foundation and Labcorp Data Show Millions Aren't Tested for Kidney Disease
07:15am, Thursday, 05'th Aug 2021
NEW YORK, Aug. 5, 2021 /PRNewswire/ -- New data suggest that millions of patients most at-risk for life-threatening kidney disease are unaware they have it because they are not tested according to cli
Laboratory Corporation of America Holdings (LH) CEO Adam Schechter on Q2 2021 Results - Earnings Call Transcript
02:09pm, Thursday, 29'th Jul 2021
Laboratory Corporation of America Holdings (LH) CEO Adam Schechter on Q2 2021 Results - Earnings Call Transcript
LabCorp (LH) Q2 Earnings Surpass Estimates, 2021 View Raised
12:10pm, Thursday, 29'th Jul 2021
LabCorp (LH) Diagnostics revenues in the second quarter increase significantly on organic Base Business volume improvements despite decelerating demand for COVID-19 testing.
LabCorp (LH) Q2 Earnings and Revenues Beat Estimates
09:53am, Thursday, 29'th Jul 2021
LabCorp (LH) delivered earnings and revenue surprises of 8.69% and 7.08%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Recap: Laboratory Corp Q2 Earnings
07:42am, Thursday, 29'th Jul 2021
Shares of Laboratory Corp (NYSE:LH) remained unaffected after the company reported Q2 results. Quarterly Results Earnings per share increased 138.52% over the past year to $6.13, which beat the estima
Labcorp Announces 2021 Second Quarter Results
07:01am, Thursday, 29'th Jul 2021
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading life sciences company, today announced results for the second quarter ended June 30, 2021, and raised full-year guidance. “Our strate
LabCorp (LH) to Report Q2 Earnings: What's in the Cards? (revised)
02:27pm, Wednesday, 28'th Jul 2021
LabCorp's (LH) second-quarter base-business performance is expected to have registered a faster recovery rate compared to the first quarter.
LabCorp (LH) Soars to 52-Week High, Time to Cash Out?
10:46am, Monday, 26'th Jul 2021
LabCorp (LH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
LabCorp (LH) to Report Q2 Earnings: What's in the Cards?
10:44am, Friday, 23'rd Jul 2021
LabCorp's (LH) second-quarter base-business performance is expected to have registered a faster recovery rate compared to the first quarter.
LH vs. CNMD: Which Stock Should Value Investors Buy Now?
01:12pm, Friday, 16'th Jul 2021
LH vs. CNMD: Which Stock Is the Better Value Option?
The Perfect 10 Portfolio Returned 69% Last Year
10:43am, Monday, 12'th Jul 2021
To call a beautiful woman a “Perfect 10” these days would be considered chauvinistic and outdated.
Here's Why You Should Add LabCorp (LH) Stock to Your Portfolio
10:06am, Monday, 12'th Jul 2021
Investors are optimistic about LabCorp (LH) backed by strong diagnostic arm growth and improvement in base business.
5 Lucrative Picks Based on PEG Ratio for GARP Investors
11:16am, Tuesday, 06'th Jul 2021
Here are five out of the 10 stocks, ASO, LB, PTR, LH, and HIBB, based on hybrid GARP investment strategy.
LabCorp (LH) Expands Testing Portfolio With the Launch of CDx
09:01am, Monday, 05'th Jul 2021
LabCorp's (LH) new test expands the company's leadership in bringing testing solutions for new precision medicines used to treat patients with lung cancer.
Labcorp to Announce Second Quarter Financial Results on July 29, 2021
06:59am, Friday, 02'nd Jul 2021
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, will release its financial results for the second quarter of 2021 before the market opens on Thursday, Ju
